The global market for Peripheral Artery Disease (PAD) treatments has been witnessing significant growth, with the market size valued at $3,524.77 million in 2019. It is projected to escalate to $5,715 ...

Fierro started physical therapy — with the goal of being healthy enough in time to bounce kids on his knee as the beloved ...

Among older veterans with type 2 diabetes (T2D), the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors as an add-on ...

Allegheny Health Network Wexford Hospital introduced two new types of surgeries recently, including the region’s first ...

Atherosclerosis happens when a fatty substance called plaque builds up inside your arteries. There are typically few ...

Two men in Rochester, N.Y., died after being infected with a rare fungus found in bat feces, which is sometimes used as ...

A Durham company secured federal approval for its bioengineered tissue, which could become a revolutionary treatment for ...

In contrast to coronary artery disease, many fewer clinical trials have been performed to test the effects of atherosclerotic risk factor treatment on prevention of cardiovascular events.

Lake Street analyst Frank Takkinen reiterated a Buy rating on Lemaitre Vascular (LMAT – Research Report) today and set a price target of ...

Biotronik announced the enrollment of the first patients in its BIO-OSCAR FIRST trial, which is designed to confirm the ...

Two men from New York died from pneumonia they contracted from bat feces — after they used the excrement as fertilizer to ...

A judge ruled that lawyers for former Minneapolis police officer Derek Chauvin can get tests done on preserved samples of ...